Desonate

Product manufactured by Leo Pharma Inc.

Application Nr Approved Date Route Status External Links
NDA021844 None Topical None Google , Wikipedia , PubMed , DailyMed , Raw OpenFDA , ECHA , ToxNet , JECFA , FAO , 21 CFR

Indications and Purposes

1 Indications And Usage Desonate Is Indicated For The Treatment Of Mild To Moderate Atopic Dermatitis In Patients 3 Months Of Age And Older. Patients Should Be Instructed To Use Desonate For The Minimum Amount Of Time As Necessary To Achieve The Desired Results Because Of The Potential For Desonate To Suppress The Hypothalamic-Pituitary-Adrenal (Hpa) Axis [See Warnings And Precautions (5.1)]. Treatment Should Not Exceed 4 Consecutive Weeks [See Dosage And Administration (2)]. Desonate Is A Corticosteroid Indicated For The Topical Treatment Of Mild To Moderate Atopic Dermatitis In Patients 3 Months Of Age And Older. (1)

All Formulated Excipients (0 Total)

None

Active Ingredients ( 1 Total)

Name Structure ZINC ID(s)
1. Desonide DESONIDE ZINC4212851

Comments